Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,448.00    8.00 (0.56%)
Bid:
1,442.00
Ask:
1,448.00
Spread: 6.00 (0.416%)
Market Cap: £495.75m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Trading Statement

11 Jan 2008 07:01

Craneware plc11 January 2008 Craneware plc ("Craneware" or the "Company") H1 TRADING UPDATE 11 January 2008 - Craneware plc, (AIM: CRW) a leader in revenue cyclemanagement software solutions for the US healthcare market, is pleased to givean update today on trading during the half year to 31 December 2007. Following the Company's IPO on AIM in September 2007, Craneware has executed onits strategy to further advance its market leading position. In the six monthsto 31 December 2007, the Company signed up 96 new hospitals, compared to 64 inthe previous corresponding period. As a result, the Company's software is nowbeing used in 878 hospitals in the US, up from 800 at the beginning of the year. Revenue for the first half of the year was in line with management expectations,with new sales bookings being over 50% higher than the previous correspondingperiod. Craneware's flagship product, Chargemaster Toolkit(R), was also onceagain named top in its class by the prestigious industry research house KLAS inthe US. As stated at the time of the IPO, the Company believes there is a significantopportunity to sell additional software products into its customer base and assuch has added two further products to its suite aimed at the finance departmentof US hospitals. In November, Craneware launched Patient Charge Estimator(TM),which enables hospitals to efficiently and accurately provide prospectivepatients with estimates of procedural charges. Yesterday the Company launchedPharmacy ChargeLink(TM) which enables hospitals to improve the buying, billing and reimbursement of pharmacy items. Craneware has started the second half of the year with a strong pipeline ofsales prospects and this together with the new product launches gives managementconfidence for the Company's performance for the full year. Overall, significantprogress has been made in H1 and the Company anticipates further positivenewsflow in H2. Craneware will be announcing Interim results on Tuesday 26thFebruary 2008. Keith Neilson, CEO of Craneware, commented, "We are delighted with the progressmade during the first few months of life as a public company. Cranewarecontinues to grow and we have maintained our leading position as a provider ofrevenue cycle management software to US hospitals. The complexity of legislationgoverning this sector, and the high proportion of hospitals still using manualsolutions to manage their revenue cycles, means we are operating in a vibrantmarketplace with opportunity for growth alongside continuing high levels ofcontract renewals. We look forward to updating shareholders in February." For further information, please contact: Craneware plc KBC Peel Hunt ICIS+44 (0)1506 407 666 +44 (0)20 7418 8900 +44 (0)20 7651 8688Keith Neilson, CEO Oliver Scott Tom MoriartySandy McDougall, CFO Deon Veldtman Caroline Evans-Jones About Craneware Founded in 1999, Craneware has headquarters in Livingston, Scotland, withoffices in Florida, Arizona and Kansas, employing approximately 100 staff. TheCompany's flagship product, Chargemaster Toolkit(R) ("CMT"), assists UShealthcare providers in reducing billing errors, ensuring the timely andaccurate submission of claims and managing compliance risk. More informationabout Craneware plc and its services can be found on-line at the Company'scorporate website, www.craneware.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Mar 20175:04 pmRNSDividend Currency Election
27th Mar 20176:26 pmRNSGrant of Options & Long Term Incentive Plan Award
23rd Mar 20177:00 amRNSSignificant Contract Win
7th Mar 20177:00 amRNSHalf-year Report
31st Jan 20177:00 amRNSDirector/PDMR Shareholding
17th Jan 20177:00 amRNSTrading Update
11th Nov 20164:46 pmRNSDividend Currency Election
11th Nov 20163:03 pmRNSTotal Voting Rights
11th Nov 201612:06 pmRNSBlock listing Interim Review
8th Nov 20166:08 pmRNSResult of AGM
8th Nov 20167:00 amRNSAGM Statement
31st Oct 20165:03 pmRNSPosting of Annual Report and Notice of AGM
7th Oct 20167:00 amRNSGrant of Options - Replacement
6th Oct 201611:02 amRNSTotal Voting Rights
20th Sep 20167:00 amRNSDirector/PDMR Shareholding
13th Sep 20162:48 pmRNSGrant of Options
6th Sep 20167:00 amRNSFinal Results
10th Aug 20168:26 amRNSHolding(s) in Company
6th Jul 20167:00 amRNSTrading Update, Contract Win and Notice of Results
4th Jul 201611:11 amRNSHolding(s) in Company
13th May 20167:00 amRNSTotal Voting Rights
22nd Apr 20161:04 pmRNSBlock listing Interim Review
11th Apr 20167:00 amRNSTotal Voting Rights
18th Mar 201610:44 amRNSDividend Currency Election
9th Mar 20167:00 amRNSGrant of Options
8th Mar 20167:00 amRNSHalf Yearly Report
10th Feb 20161:55 pmRNSTotal Voting Rights
2nd Feb 20167:00 amRNSSignificant Contract Win and Reseller Agreement
22nd Jan 20167:00 amRNSTrading Update
30th Nov 20155:04 pmRNSTotal Voting Rights
20th Nov 20152:26 pmRNSDividend Currency Election
17th Nov 201510:29 amRNSResult of AGM
17th Nov 20157:00 amRNSAGM Statement
13th Nov 20153:50 pmRNSHolding(s) in Company
21st Oct 20157:00 amRNSPosting of Annual Report & Notice of AGM
16th Oct 201512:44 pmRNSBlocklisting Interim Review
8th Sep 20157:00 amRNSFinal Results
16th Jul 20157:00 amRNSTrading Update and Notice of Results
27th Mar 20159:35 amRNSDividend Currency Election
10th Mar 20157:03 amRNSInterim Results
10th Mar 20157:03 amRNSStrategic Partnership with Aridhia Informatics
11th Feb 20157:00 amRNSNotice of Results
14th Jan 20157:00 amRNSTrading Update
14th Nov 201412:10 pmRNSDividend Currency Election
11th Nov 20143:35 pmRNSResult of AGM
11th Nov 20147:00 amRNSAGM Statement
17th Oct 20147:00 amRNSPosting of Annual Report & Notice of AGM
16th Oct 201412:05 pmRNSBlocklisting Interim Review
15th Oct 20147:00 amRNSDirector/PDMR Shareholding
7th Oct 201411:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.